Manufacturer record
Modi Antibiotics: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Modi Antibiotics (Gujarat) were declared Not of Standard Quality between February 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
10 records linked to Modi Antibiotics in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| ASPIRIN TABLET IP 75MG | 240968Mfg 2024-09 · Exp 2027-08 | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN TABLET IP 75MG | 250168Mfg 2025-01 · Exp 2027-12 | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN TABLETS I.P. 75 MG | 241271Mfg 2024-12 · Exp 2027-11 | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets.2 ) The Content of Aspirin in the Sample is less (i.e. 69.84% of Stated amount) than the IP Limits. (IP Limit - Not less than 95% and Not more than 105% of stated Amount)Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab | Nov 2025 |
| ASPIRIN TABLETS I.P. 75 MG | 240604Mfg 2024-06 · Exp 2027-05 | 1 ) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets. 2 )The Sample does not give IP Identification for the Presence of Aspirin. 3 ) The Sample gives additional Identification for the Presence of Salicylic Acid. 4 ) Found Content of Salicylic Acid in the Sample is 73.68 mg/Tablet.Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab | Nov 2025 |
| Domperidone Tablets I.P. 10 mg | 240909Mfg 2024-09 · Exp 2027-08 | Domperidone Maleate and DescriptionDescription | CDTL, IndoreCDSCO lab | Aug 2025 |
| Bisacodyl Tablets I.P. 5 mg (Laxagen) | 230754Mfg 2023-07 · Exp 2026-06 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Jan 2024 |
| (DUCOLAX) Bisacodyl Tablet I.P. 5 mg | 220259Mfg 2022-02 · Exp 2025-01 | Assay and DissolutionAssay | CDTL KolkataCDSCO lab | Mar 2023 |
| Paracetamol Tablets I.P. 500 mg | 220124Mfg 2022-01 · Exp 2024-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2022 |
| Primaquine Tablets I.P. 7.5 mg. | 191134Mfg 2019-11 · Exp 2022-10 | AssayAssay | RDTL GuwahatiCDSCO lab | Aug 2022 |
| Chloroquine Phosphate Tablets IP 250 mg | 170819Mfg 2017-08 · Exp 2020-07 | Dissolution (Chloroquine Phosphate).Dissolution | CDSCO, North Zone, GZBCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.